Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Breast Cancer Res Treat. 2009 Mar 22;120(1):25–34. doi: 10.1007/s10549-009-0357-6

Figure 2. Classification of relapse of tamoxifen-treated primary breast cancers.

Figure 2

Figure 2

(A) Comparison of ROC curve of the malignancy risk score among the four gene signatures. (B) Distribution of the malignancy-risk scores among the two groups, relapse and relapse-free.